GE Healthcare is collaborating with the American College of Cardiology (ACC) through support of and participation in the ACC’s Applied Health Innovation Consortium for the purpose of building a roadmap for Artificial Intelligence (AI) and digital technology in cardiology and developing new strategies for improved health outcomes.
The Consortium brings together academic, clinical, industry, and technology partners and patient advocates, to collaborate in the digital transformation of healthcare and achieve trust in the development of clinical evidence and guidance.
“We are excited to have GE Healthcare join forces with the Applied Health Innovation Consortium,” says John Rumsfeld, ACC’s chief innovation officer and chief science & quality officer. “In our mission to transform cardiovascular care and improve heart health, GE Healthcare is a great collaborator to help build a roadmap for AI and digital technology that bridges gaps in clinical care.”
“We are eager to help shape the heart care pathway—from early detection to treatment to follow-up at home—by combining our expertise in AI and digital technologies with top clinical leadership to advance risk prediction and decision-making support,” says Eigil Samset, chief technology scientist for cardiology solutions at GE Healthcare. “Ultimately, this will enable precision health, which is doing the right thing, at the right time for every patient, at scale—with the ultimate goal to provide better outcomes, delivered to more people, more cost efficiently.”
The collaboration will start tackling the challenges related to atrial fibrillation management along with other care pathways in cardiology including coronary artery disease, valvular heart disease and heart failure.
